Clinical Trial Update: Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 study assessing efficacy and safety of Hemay005 in moderate to severe plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Hemay005

Snippet

Sponsor: Tianjin Hemay Pharmaceutical Co., Ltd | Conditions: Psoriasis | Phase 2 | Status: COMPLETED